New Delhi: Indian companies have committed a record USD20.5 billion in investments into the US, announced at the 2026 SelectUSA Investment Summit held in Maryland, marking a landmark moment in bilateral economic ties between the two nations.
The investments span several strategic sectors, including pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies, the US Embassy in New Delhi said in a press release.
Officials said the commitments are expected to generate thousands of jobs across both countries while boosting American production capacity and fostering joint innovation. The bulk of the pledged capital comes from India’s pharmaceutical industry, which accounts for over USD 19.1 billion earmarked for US manufacturing facilities, research and development operations, and new infrastructure.
The remaining investments are directed at strengthening American industrial capacity in steel, connectivity, and energy supply chains, to build more secure and resilient production networks.
Separately, 12 Indian companies announced greenfield and expansion projects worth more than USD 1.1 billion across multiple US states, targeting job creation in manufacturing, technology, and engineering. Officials noted that these announcements surpass the combined total of all previous Indian investment announcements at prior SelectUSA summits and represent the highest number of commitments by any single country at this year’s edition.
US Ambassador Sergio Gor, speaking at the SelectUSA kick-off reception in New Delhi, said the investments advanced the shared ambition of doubling US-India bilateral trade to USD500 billion by 2030. He said that through fair and mutually beneficial trade, the US was attracting world-class investment and creating shared prosperity for both nations.
The SelectUSA Investment Summit is the US government’s flagship event for facilitating foreign business investment, bringing together investors, companies, economic development organisations, and industry experts to identify opportunities and forge commercial partnerships.
